Rethinking Clinical Trials

MARCH 6, 2024

Schell Professor of Management and Applied Economics MIT Sloan School of Management Slides Keywords Food-as-Medicine, Randomized Clinical Trial, Diabetes Key Points Diabetes is common and costly. Food insecurity is associated with diabetes. Clinic staff included a dietitian, a nurse and a community health worker.

Clinical Trials 141

Clinical Trials Clinical Trials Medicine Trials 141

Rethinking Clinical Trials

JULY 6, 2023

Over the past several years, a variety of factors have accelerated the need for decentralized trials, including the push to make trials more accessible, the increased speed of science, the possibility of environmentally conscious trials, and the need to be flexible in a rapidly changing world.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

Rethinking Clinical Trials

OCTOBER 18, 2023

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health. For example, consider food security.

Clinical Trials 117

Clinical Trials Clinical Trials Clinical Research Research 117

Rethinking Clinical Trials

SEPTEMBER 21, 2023

Behavioral nudges may increase healthy food purchasing by “nudging” consumers to purchase healthier options by providing discounts or lower-cost options. These findings suggest that the expansion of nutrition incentives to online settings is a potentially promising strategy to promote equitable access to food.

Clinical Trials 130

Clinical Trials Clinical Trials Sales Trials 130

Rethinking Clinical Trials

JUNE 29, 2022

Food and Drug Administration (FDA). Real-world evidence (RWE) is clinical evidence derived from analysis of RWD regardless of study design. The post June 24, 2022: FDA Draft Guidance on Real-World Evidence (John Concato, MD, MS, MPH) appeared first on Rethinking Clinical Trials. John Concato, MD, MS, MPH. Key Points.

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

Rethinking Clinical Trials

FEBRUARY 7, 2024

Winckler, RPh, Esq Chief Executive Officer Reagan-Udall Foundation for the FDA Slides Keywords U.S. Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. Winckler, RPh, Esq) appeared first on Rethinking Clinical Trials.             Speaker Susan C.

Regulation 152

Regulation Production Clinical Trials Clinical Trials 152

Rethinking Clinical Trials

AUGUST 28, 2023

Food and Drug Administration (FDA) Slides Keywords Pragmatic trials; Research; Guidance, Regulatory, Data Governance Key Points The clinical trial enterprise needs modernization. Time, cost and failure to recruit trial participants are significant barriers that must be addressed.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130